# ChronoScale Holdings Corp: financial statements, quarterly

CHRN · Nasdaq · CIK 1549084 · [Industrials](/sectors/industrials.md) · fiscal year ends May 31

Pages: [Overview](/companies/chrn.md) · [Financials](/companies/chrn/financials.md) · [Filings](/companies/chrn/filings.md) · [Insiders](/companies/chrn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/chrn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | period not labelled (2025-08-31) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4.8 d](/filings/0001437749-25-005913.md) | [3.8](/filings/0001437749-25-014528.md) | [5.0](/filings/0001437749-25-023648.md) | [4.1](/filings/0001437749-25-031960.md) | [5.1 d](/filings/0001437749-26-005086.md) | [3.4](/filings/0001437749-26-013682.md) | [2.1](/filings/0001437749-25-023648.md) | [16.7](/filings/0001628280-26-065876.md) | [4.2](/filings/0001437749-25-031960.md) | [3.1 d](/filings/0001437749-26-005086.md) | [2.1](/filings/0001437749-26-013682.md) | [41.5](/filings/0001628280-26-065876.md) |
| Cost of revenue | $m | [2.5 d](/filings/0001437749-25-005913.md) | [1.8](/filings/0001437749-25-014528.md) | [2.3](/filings/0001437749-25-023648.md) | [1.9](/filings/0001437749-25-031960.md) | [2.4 d](/filings/0001437749-26-005086.md) | [1.6](/filings/0001437749-26-013682.md) | [1.2](/filings/0001437749-25-023648.md) | [23.9](/filings/0001628280-26-065876.md) | [1.7](/filings/0001437749-25-031960.md) | [1.5 d](/filings/0001437749-26-005086.md) | [1.1](/filings/0001437749-26-013682.md) | [45.6](/filings/0001628280-26-065876.md) |
| Gross profit | $m | [2.4 d](/filings/0001437749-25-005913.md) | [2.0](/filings/0001437749-25-014528.md) | [2.6](/filings/0001437749-25-023648.md) | [2.2](/filings/0001437749-25-031960.md) | [2.7 d](/filings/0001437749-26-005086.md) | [1.8](/filings/0001437749-26-013682.md) | [0.8](/filings/0001437749-25-023648.md) | not reported | [2.5](/filings/0001437749-25-031960.md) | [1.7 d](/filings/0001437749-26-005086.md) | [1.1](/filings/0001437749-26-013682.md) | not reported |
| Research and development | $m | [1.3 d](/filings/0001437749-25-005913.md) | [1.1](/filings/0001437749-25-014528.md) | [1.1](/filings/0001437749-25-023648.md) | [0.8](/filings/0001437749-25-031960.md) | [0.8 d](/filings/0001437749-26-005086.md) | [1.0](/filings/0001437749-26-013682.md) | [0.9](/filings/0001437749-25-023648.md) | not reported | [0.6](/filings/0001437749-25-031960.md) | [0.6 d](/filings/0001437749-26-005086.md) | [0.6](/filings/0001437749-26-013682.md) | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.4](/filings/0001628280-26-065876.md) | not reported | not reported | not reported | [20.7](/filings/0001628280-26-065876.md) |
| Operating income | $m | [(3.4) d](/filings/0001437749-25-005913.md) | [(3.3)](/filings/0001437749-25-014528.md) | [(2.3)](/filings/0001437749-25-023648.md) | [(2.6)](/filings/0001437749-25-031960.md) | [(2.2) d](/filings/0001437749-26-005086.md) | [(3.4)](/filings/0001437749-26-013682.md) | [(4.0)](/filings/0001437749-25-023648.md) | [(8.0)](/filings/0001628280-26-065876.md) | [(1.4)](/filings/0001437749-25-031960.md) | [(4.5) d](/filings/0001437749-26-005086.md) | [(5.6)](/filings/0001437749-26-013682.md) | [(24.9)](/filings/0001628280-26-065876.md) |
| Interest expense | $m | [0.1 d](/filings/0001437749-24-006423.md) | [0.1](/filings/0001437749-24-013696.md) | [0.1](/filings/0001437749-25-023648.md) | [0.1](/filings/0001437749-25-031960.md) | [0.1 d](/filings/0001437749-26-005086.md) | [0.1](/filings/0001437749-26-013682.md) | [0.1](/filings/0001437749-25-023648.md) | not reported | [0.0](/filings/0001437749-25-031960.md) | [0.2 d](/filings/0001437749-26-005086.md) | [0.1](/filings/0001437749-26-013682.md) | not reported |
| Net income | $m | [(3.2) d](/filings/0001437749-25-005913.md) | [(3.4)](/filings/0001437749-25-031960.md) | [(2.4)](/filings/0001437749-25-031960.md) | [(2.1)](/filings/0001437749-25-031960.md) | [(3.4) d](/filings/0001437749-26-005086.md) | [(2.9)](/filings/0001437749-26-013682.md) | [(2.7)](/filings/0001437749-25-031960.md) | [(11.2)](/filings/0001628280-26-065876.md) | [(1.4)](/filings/0001437749-25-031960.md) | [(4.7) d](/filings/0001437749-26-005086.md) | [(6.9)](/filings/0001437749-26-013682.md) | [(42.5)](/filings/0001628280-26-065876.md) |
| Diluted EPS | $ per share | not reported | [(0.20)](/filings/0001437749-25-014528.md) | [(1.99)](/filings/0001437749-25-023648.md) | [(1.53)](/filings/0001437749-25-031960.md) | not reported | [(1.84)](/filings/0001437749-26-013682.md) | [(1.24)](/filings/0001437749-25-023648.md) | [(0.08)](/filings/0001628280-26-065876.md) | [(0.54)](/filings/0001437749-25-031960.md) | not reported | [(2.04)](/filings/0001437749-26-013682.md) | [(0.29)](/filings/0001628280-26-065876.md) |
| Basic EPS | $ per share | not reported | [(0.20)](/filings/0001437749-25-014528.md) | [(1.99)](/filings/0001437749-25-023648.md) | [(1.53)](/filings/0001437749-25-031960.md) | not reported | [(1.84)](/filings/0001437749-26-013682.md) | [(1.24)](/filings/0001437749-25-023648.md) | [(0.08)](/filings/0001628280-26-065876.md) | [(0.54)](/filings/0001437749-25-031960.md) | not reported | [(2.04)](/filings/0001437749-26-013682.md) | [(0.29)](/filings/0001628280-26-065876.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | period not labelled (2025-05-31) | Q2 FY2025 (2025-06-30) | period not labelled (2025-08-31) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.9](/filings/0001437749-24-023765.md) | [8.3](/filings/0001437749-24-032291.md) | [4.5](/filings/0001437749-26-005086.md) | [8.1](/filings/0001437749-25-014528.md) | [2.4](/filings/0001628280-26-058018.md) | [5.2](/filings/0001437749-25-023648.md) | not reported | [2.7](/filings/0001437749-25-031960.md) | [1.2](/filings/0001437749-26-013682.md) | [4.0](/filings/0001437749-26-013682.md) | [9.7](/filings/0001628280-26-065876.md) | [15.2](/filings/0001628280-26-065876.md) |
| Current assets | $m | [18.6](/filings/0001437749-24-023765.md) | [21.1](/filings/0001437749-24-032291.md) | [18.8](/filings/0001437749-26-005086.md) | [20.1](/filings/0001437749-25-014528.md) | [6.4](/filings/0001628280-26-058018.md) | [16.0](/filings/0001437749-25-023648.md) | not reported | [14.8](/filings/0001437749-25-031960.md) | [14.0](/filings/0001437749-26-013682.md) | [14.1](/filings/0001437749-26-013682.md) | [44.2](/filings/0001628280-26-065876.md) | [30.7](/filings/0001628280-26-065876.md) |
| Total assets | $m | [27.0](/filings/0001437749-24-023765.md) | [29.2](/filings/0001437749-24-032291.md) | [26.7](/filings/0001437749-26-005086.md) | [27.3](/filings/0001437749-25-014528.md) | [304](/filings/0001628280-26-058018.md) | [23.2](/filings/0001437749-25-023648.md) | not reported | [21.7](/filings/0001437749-25-031960.md) | [20.1](/filings/0001437749-26-013682.md) | [19.7](/filings/0001437749-26-013682.md) | [326](/filings/0001628280-26-065876.md) | [295](/filings/0001628280-26-065876.md) |
| Current liabilities | $m | [7.7](/filings/0001437749-24-023765.md) | [7.5](/filings/0001437749-24-032291.md) | [7.5](/filings/0001437749-26-005086.md) | [8.6](/filings/0001437749-25-014528.md) | [158](/filings/0001628280-26-058018.md) | [6.7](/filings/0001437749-25-023648.md) | not reported | [8.9](/filings/0001437749-25-031960.md) | [8.6](/filings/0001437749-26-013682.md) | [9.1](/filings/0001437749-26-013682.md) | [86.9](/filings/0001628280-26-065876.md) | [101](/filings/0001628280-26-065876.md) |
| Total liabilities | $m | [14.9](/filings/0001437749-24-023765.md) | [14.3](/filings/0001437749-24-032291.md) | [13.9](/filings/0001437749-26-005086.md) | [14.6](/filings/0001437749-25-014528.md) | [228](/filings/0001628280-26-058018.md) | [12.2](/filings/0001437749-25-023648.md) | not reported | [12.0](/filings/0001437749-25-031960.md) | [11.1](/filings/0001437749-26-013682.md) | [13.9](/filings/0001437749-26-013682.md) | [144](/filings/0001628280-26-065876.md) | [145](/filings/0001628280-26-065876.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [12.0](/filings/0001628280-26-058018.md) | not reported | not reported | not reported | not reported | not reported | [0.5](/filings/0001628280-26-065876.md) | [0.2](/filings/0001628280-26-065876.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-058018.md) | not reported | not reported | not reported | not reported | not reported | [3.4](/filings/0001628280-26-065876.md) | [10.5](/filings/0001628280-26-065876.md) |
| Shareholders' equity | $m | [12.1](/filings/0001437749-25-031960.md) | [14.9](/filings/0001437749-25-031960.md) | [12.7](/filings/0001437749-26-013682.md) | [12.7](/filings/0001437749-26-013682.md) | [76.2](/filings/0001628280-26-065876.md) | [10.9](/filings/0001437749-25-031960.md) | [89.2](/filings/0001628280-26-065876.md) | [9.7](/filings/0001437749-25-031960.md) | [9.0](/filings/0001437749-26-013682.md) | [2.1](/filings/0001437749-26-013682.md) | [180](/filings/0001628280-26-065876.md) | [151](/filings/0001628280-26-065876.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | period not labelled (2025-08-31) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.6) d](/filings/0001437749-25-005913.md) | [(3.5)](/filings/0001437749-25-014528.md) | [(2.7) d](/filings/0001437749-25-023648.md) | [(2.3) d](/filings/0001437749-25-031960.md) | [(1.4) d](/filings/0001437749-26-005086.md) | [(2.0)](/filings/0001437749-26-013682.md) | [(3.4) d](/filings/0001437749-25-023648.md) | [0.1](/filings/0001628280-26-065876.md) | [(2.1) d](/filings/0001437749-25-031960.md) | [(4.3) d](/filings/0001437749-26-005086.md) | [(2.1)](/filings/0001437749-26-013682.md) | [14.6](/filings/0001628280-26-065876.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001437749-25-005913.md) | [0.0](/filings/0001437749-25-014528.md) | [0.0 d](/filings/0001437749-25-023648.md) | [0.0 d](/filings/0001437749-25-031960.md) | [0.0 d](/filings/0001437749-26-005086.md) | [0.0](/filings/0001437749-26-013682.md) | [0.0 d](/filings/0001437749-25-023648.md) | [1.0](/filings/0001628280-26-065876.md) | [0.0 d](/filings/0001437749-25-031960.md) | [0.1 d](/filings/0001437749-26-005086.md) | [0.0](/filings/0001437749-26-013682.md) | [3.1](/filings/0001628280-26-065876.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q3 FY2021 (2021-09-30) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2025-08-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.7](/filings/0001549084-22-000071.md) | [12.7](/filings/0001549084-23-000019.md) | [12.9](/filings/0001437749-23-020898.md) | [13.1](/filings/0001437749-23-029099.md) | [13.3](/filings/0001437749-24-013696.md) | [13.6](/filings/0001437749-24-023765.md) | [14.1](/filings/0001437749-24-032291.md) | [17.4](/filings/0001437749-24-013696.md) | [18.2](/filings/0001437749-24-023765.md) | [20.3](/filings/0001437749-24-032291.md) | [138](/filings/0001628280-26-065876.md) | [145](/filings/0001628280-26-065876.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 145,637,452 at 2026-10-13, from the cover of the [10-Q filed 2026-10-14](/filings/0001628280-26-065876.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.